Centre Hospitalier de Jolimont, Jolimont, Belgium.
Nutr Clin Pract. 2012 Aug;27(4):527-32. doi: 10.1177/0884533612449360. Epub 2012 Jun 15.
The aim of this study was to assess the correlation between plasma citrulline and Sequential Organ Failure Assessment (SOFA) score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, survival, inflammation (C-reactive protein [CRP]), inotrope use, serum levels of prealbumin and albumin, and renal failure in the critically ill patient.
This prospective observational single-center controlled study included 91 adult patients over a 2-year period. Inclusion criteria were patients staying in the intensive care unit for >48 hours. Patients' renal status was categorized as those with a glomerular filtration rate (GFR) >60 mL/min without renal support, a GFR >60 mL/min with renal support, a GFR <60 mL/min without renal support, and a GFR <60 mL/min with renal support. Plasma citrulline concentrations were categorized into 3 groups: low (0-15 µmol/L), medium (16-35 µmol/L), and high (>36 µmol/L). The relationship between the recorded parameters and these different cut-off values of plasma citrulline concentrations was analyzed.
Ninety-one patients (34% female and 66% male) with a mean (SD) age of 69.3 (11.9) years, a mean (SD) body mass index of 24.8 (5.34) kg/m(2), a mean (SD) APACHE II score of 22.4 (7.92), a mean (SD) SOFA score of 8 (4.4), and a mean (SD) plasma citrulline of 21.7 (13.1) µmol/L were enrolled. Only patients with intestinal dysfunction had low plasma citrulline level <15 µmol/L (P = .014). No correlations between serum levels of CRP, albumin, or prealbumin; renal failure; inotrope use; SOFA score; and APACHE II score were found with plasma citrulline level.
Low plasma citrulline levels in patients correlate well with intestinal dysfunction.
本研究旨在评估血浆瓜氨酸与序贯器官衰竭评估(SOFA)评分、急性生理学和慢性健康评估 II 评分(APACHE II)、生存率、炎症(C 反应蛋白 [CRP])、正性肌力药使用、血清前白蛋白和白蛋白水平以及危重症患者肾功能衰竭之间的相关性。
这是一项为期 2 年的前瞻性观察性单中心对照研究,纳入了 91 名成年患者。纳入标准为入住重症监护病房超过 48 小时的患者。患者的肾功能状态分为肾小球滤过率(GFR)>60 mL/min 无肾脏支持、GFR>60 mL/min 有肾脏支持、GFR<60 mL/min 无肾脏支持和 GFR<60 mL/min 有肾脏支持。将血浆瓜氨酸浓度分为 3 组:低(0-15 μmol/L)、中(16-35 μmol/L)和高(>36 μmol/L)。分析记录参数与血浆瓜氨酸浓度不同临界值之间的关系。
91 例患者(34%为女性,66%为男性),平均年龄(标准差)为 69.3(11.9)岁,平均(标准差)体重指数为 24.8(5.34)kg/m2,平均(标准差)APACHE II 评分为 22.4(7.92),SOFA 评分为 8(4.4),血浆瓜氨酸平均(标准差)为 21.7(13.1)μmol/L。只有存在肠道功能障碍的患者血浆瓜氨酸水平<15 μmol/L(P =.014)。未发现 CRP、白蛋白或前白蛋白血清水平、肾功能衰竭、正性肌力药使用、SOFA 评分和 APACHE II 评分与血浆瓜氨酸水平之间存在相关性。
患者的低血浆瓜氨酸水平与肠道功能障碍密切相关。